Published in J Vis Exp on January 15, 2015
Multistage vector (MSV) therapeutics. J Control Release (2015) 0.84
A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells. Pharmacol Res (2016) 0.78
Post-nano strategies for drug delivery: Multistage porous silicon microvectors. J Mater Chem B Mater Biol Med (2016) 0.75
Enzyme-responsive multistage vector for drug delivery to tumor tissue. Pharmacol Res (2016) 0.75
Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma. Cancer Lett (2017) 0.75
Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov (2009) 12.46
Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov (2007) 6.37
Nonviral vectors for gene delivery. Chem Rev (2009) 4.08
Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release (2009) 3.08
siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev (2009) 2.21
Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat Nanotechnol (2010) 2.17
Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev (2006) 1.95
Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials (2007) 1.72
Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjug Chem (2008) 1.62
Nanomedicine based approaches for the delivery of siRNA in cancer. J Intern Med (2010) 1.36
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery. Clin Cancer Res (2013) 1.21
Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy. Small (2013) 1.05
High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. ACS Nano (2013) 0.98
Degradation and biocompatibility of multistage nanovectors in physiological systems. J Biomed Mater Res A (2013) 0.90
Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells. Biomaterials (2013) 0.85
Dose-dependent movement of cationic molecules across the glomerular wall. Anat Rec (1985) 0.84
Gene medicines: the end of the beginning? Adv Drug Deliv Rev (2005) 0.83